Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 1051 AL 1065

Synergistic potential of TREM2 agonists and exercise training in Alzheimer's disease

Zhang J, St Pierre Schneider B, Muguerza E, Chung E, Hsu CG.

Am J Physiol Endocrinol Metab. 2026 Mar 1;330(3):E298-E308. doi: 10.1152/ajpendo.00124.2025. Epub 2026 Jan 6.

Redox-sensitive high mobility group box 1 (HMGB1) protein is a multipotent regulator in the pathogenesis of Alzheimer's disease

Salminen A.

Neurochem Int. 2026 Feb;193:106115. doi: 10.1016/j.neuint.2026.106115. Epub 2026 Jan 5.

Amyloid-β and Tau in Alzheimer's disease: pathogenesis, mechanisms, and interplay

Abdulkhaliq AA, Kim B, Almoghrabi YM, Khan J, Ajoolabady A, Ren J, Bahijri S, Tuomilehto J, Borai A, Pratico D.

Cell Death Dis. 2026 Jan 9;17(1):21. doi: 10.1038/s41419-025-08186-8.

A Question of Origins: Non-neuronal Sources of Amyloid-β

Sasmita AO, Depp C.

Neurosci Bull. 2026 May;42(5):1126-1150. doi: 10.1007/s12264-025-01572-4. Epub 2026 Jan 19.

Engineering nanobodies for drug delivery systems in Alzheimer's disease

Jootar T, Hongeng S, Chiangjong W.

Artif Cells Nanomed Biotechnol. 2026 Dec;54(1):104-118. doi: 10.1080/21691401.2026.2617707. Epub 2026 Jan 22.

The role of galanin/GALR2 signaling in the link between type 2 diabetes and Alzheimer's disease

Xu M, Wang J, She Y, He J, Yu M, Zhang Z, Fang P.

Neuropeptides. 2026 Apr;116:102586. doi: 10.1016/j.npep.2026.102586. Epub 2026 Jan 18.

Smart Biosensing Nanomaterials for Alzheimer's Disease: Advances in Design and Drug Delivery Strategies to Overcome the Blood-Brain Barrier

Rajkumar M, Tian F, Javed B, Prajapati BG, Deepak P, Girigoswami K, Karmegam N.

Biosensors (Basel). 2026 Jan 21;16(1):66. doi: 10.3390/bios16010066.

Targeting the Gut Microbiota: Mechanistic Investigation of Polyphenol Modulation of the Gut-Brain Axis in Alzheimer's Disease

Wang Z, Ba S, Li M, Wei Y, Wang Y, Mao J, Xiang Y, Qin D, Zeng C.

Int J Mol Sci. 2026 Jan 7;27(2):604. doi: 10.3390/ijms27020604.

Unrevealing role of TLRs/NLRP receptors in halting Alzheimer's neuroinflammation: Current progress and existing therapies

Upadhayay S.

Int Immunopharmacol. 2026 Mar 15;173:116285. doi: 10.1016/j.intimp.2026.116285. Epub 2026 Jan 29.

Alzheimer's Disease: Evolving Therapeutics, Scientific Progress, and Key Challenges

K SY, Goswami AK, Prasad MR, Chauhan VS, Yadav N.

J Med Chem. 2026 Feb 26;69(4):3693-3718. doi: 10.1021/acs.jmedchem.5c02468. Epub 2026 Feb 13.

Neuroinflammation in Alzheimer's Disease: The Role of Obesity, Gut Microbiota, and Therapeutic Potential of Omega-3 Fatty Acids and Neural Stem Cells

Morovati A, Moussa Y, Kalupahana NS, Zu Y, Jun H, Fokar M, Moustaid-Moussa N.

J Nutr. 2026 Apr;156(4):101407. doi: 10.1016/j.tjnut.2026.101407. Epub 2026 Feb 11.

Immunometabolism Reframes Alzheimer's Disease: From Systemic Dysmetabolism to Glial Rewiring

Bach DH, Nguyen TL.

Cell Mol Neurobiol. 2026 Feb 13;46(1):56. doi: 10.1007/s10571-026-01691-0.

Microglial metabolic reprogramming in Alzheimer's disease: Pathways, mechanisms, and therapeutic implications

Yang FG, Yang H, Han SW, Wang JT, Gao W, Ye QY, Zhang MM, Yang Y, Li HL.

Ageing Res Rev. 2026 Apr;116:103050. doi: 10.1016/j.arr.2026.103050. Epub 2026 Feb 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias